Topic: manufacturing plant
Gilead has opened its new $11 million manufacturing facility control lab in Ireland.
Neopharma and ASKA Pharmaceuticals entered a joint venture to build a $53 million pharmaceutical manufacturing facility in India.
Corona Remedies acquired two drug brands from Abbott India and said it plans to invest $11.1 million in building a new manufacturing facility.
Heritage Pharmaceuticals, based in East Brunswick, New Jersey, opened a new manufacturing facility that was built using modular cleanroom walls.
North Carolina-based drug manufacturer Panaceutics said it will invest $5.8 million in a facility in Pittsylvania County, Virginia.
Takeda made two R&D deals, China's crackdown on pollution causes pharma supply issues, Merck KGaA plans production expansions in Asia.
Mylan and Biocon win CHMP nod for a Lantus biosimilar, Takeda's Zika vaccine fast-tracked by the FDA, Celltrion got a warning letter.
Israeli officials have a solution for reducing the number of local Teva employees set to lose their jobs: Close plants in Ireland instead.
Some generics makers are responding to industrywide pricing pressure by bulking up via M&A. Not Novartis.
Generic API maker Cambrex said it will begin a $3.5 million project to improve wastewater processing capabilities at its facility in Sweden.